Peter Scheurich
6Patents
3h-index
15Co-inventors
54Inventor score
Filing activity: Feb 12, 1991 → Apr 4, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7368295B2 | Nanoparticles comprising biologically active TNF which is immobilized on the same | Chemistry; Metallurgy | 12 | Expired |
| US5736138A | Monoclonal antibodies with specific binding against membrane proteins on human cells, and pharmaceutical compositions containing them | Emerging Cross-Sectional Technologies | 10 | Expired |
| US8927205B2 | Recombinant polypeptides of the members of the TNF ligand family and use thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US9045535B2 | huTNFR1 selective antagonists | Chemistry; Metallurgy | 1 | Active |
| US10689452B2 | Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof | Chemistry; Metallurgy | 0 | Active |
| US8404238B2 | huTNFR1 selective antagonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.